Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT)

CUSIP: 03969T109

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock
Shares outstanding
28,412,394
Total 13F shares
19,065,552
Share change
-1,441,819
Total reported value
$909,015,330
Put/Call ratio
54%
Price per share
$47.78
Number of holders
150
Value change
-$50,289,411
Number of buys
77
Number of sells
55

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 03969T109?
CUSIP 03969T109 identifies ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ARCT - Arcturus Therapeutics Holdings Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FEDERATED HERMES, INC.
13F
Company
11%
3,028,000
$102,468,000 30 Jun 2021
13F
ARK Investment Management LLC
13F
Company
10%
2,884,682
$97,618,000 30 Jun 2021
13F
STATE STREET CORP
13F
Company
6.2%
1,755,654
$59,411,000 30 Jun 2021
13F
BlackRock Finance, Inc.
13F
Company
6%
1,703,509
$57,647,000 30 Jun 2021
13F
Amova Asset Management Americas, Inc.
13F
Company
4.3%
1,214,901
$41,185,000 30 Jun 2021
13F
Sumitomo Mitsui Trust Group, Inc.
13F
Company
4.3%
1,214,901
$41,112,000 30 Jun 2021
13F
VANGUARD GROUP INC
13F
Company
4.2%
1,179,841
$39,926,000 30 Jun 2021
13F
ORBIMED ADVISORS LLC
13F
Company
3%
848,503
$28,713,000 30 Jun 2021
13F
Ultragenyx Pharmaceutical Inc.
3/4/5
Director
class O/S missing
1,400,000
$26,208,420 10 Aug 2021
FMR LLC
13F
Company
2.6%
730,290
$24,713,000 30 Jun 2021
13F
Bank Julius Baer & Co. Ltd, Zurich
13F
Company
2.5%
702,778
$23,782,000 30 Jun 2021
13F
ACT CAPITAL MANAGEMENT, LLC
13F
Company
1.6%
455,300
$15,408,000 30 Jun 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.4%
383,617
$12,981,000 30 Jun 2021
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
1.1%
325,493
$11,015,000 30 Jun 2021
13F
TWO SIGMA ADVISERS, LP
13F
Company
1.1%
320,343
$10,840,000 30 Jun 2021
13F
D. E. Shaw & Co., Inc.
13F
Company
1.1%
305,090
$10,324,000 30 Jun 2021
13F
JPMORGAN CHASE & CO
13F
Company
0.94%
265,750
$8,993,000 30 Jun 2021
13F
MORGAN STANLEY
13F
Company
0.87%
247,533
$8,377,000 30 Jun 2021
13F
NORTHERN TRUST CORP
13F
Company
0.83%
236,039
$7,988,000 30 Jun 2021
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
0.76%
216,923
$7,341,000 30 Jun 2021
13F
Rafferty Asset Management, LLC
13F
Company
0.66%
186,829
$6,322,000 30 Jun 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.51%
144,621
$4,894,000 30 Jun 2021
13F
CITIGROUP INC
13F
Company
0.51%
143,507
$4,856,000 30 Jun 2021
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.47%
133,741
$4,526,000 30 Jun 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.45%
128,172
$4,337,000 30 Jun 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.42%
118,210
$4,000,000 30 Jun 2021
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.38%
108,932
$3,686,000 30 Jun 2021
13F
Monashee Investment Management LLC
13F
Company
0.35%
100,000
$3,384,000 30 Jun 2021
13F
ROYCE & ASSOCIATES LP
13F
Company
0.28%
79,836
$2,702,000 30 Jun 2021
13F
Bank of New York Mellon Corp
13F
Company
0.25%
70,769
$2,395,000 30 Jun 2021
13F
PICTET ASSET MANAGEMENT LTD
13F
Company
0.21%
60,930
$2,062,000 30 Jun 2021
13F
Koss-Olinger Consulting, LLC
13F
Company
0.21%
58,800
$1,990,000 30 Jun 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.21%
58,781
$1,989,000 30 Jun 2021
13F
JACOB ASSET MANAGEMENT OF NEW YORK LLC
13F
Company
0.18%
51,000
$1,726,000 30 Jun 2021
13F
Swiss National Bank
13F
Company
0.16%
46,300
$1,567,000 30 Jun 2021
13F
Vontobel Holding Ltd.
13F
Company
0.14%
39,152
$1,325,000 30 Jun 2021
13F
SHELTON CAPITAL MANAGEMENT
13F
Company
0.13%
38,000
$1,286,000 30 Jun 2021
13F
ALPS ADVISORS INC
13F
Company
0.12%
34,665
$1,173,000 30 Jun 2021
13F
UBS Group AG
13F
Company
0.12%
33,971
$1,149,000 30 Jun 2021
13F
Snowden Capital Advisors LLC
13F
Company
0.11%
31,909
$1,079,801 30 Jun 2021
13F
MGO ONE SEVEN LLC
13F
Company
0.11%
30,216
$1,023,000 30 Jun 2021
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.11%
30,100
$1,019,000 30 Jun 2021
13F
Engineers Gate Manager LP
13F
Company
0.1%
29,749
$1,007,000 30 Jun 2021
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.1%
29,500
$998,000 30 Jun 2021
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.1%
29,123
$986,000 30 Jun 2021
13F
RHUMBLINE ADVISERS
13F
Company
0.1%
28,667
$970,000 30 Jun 2021
13F
PLATINUM INVESTMENT MANAGEMENT LTD
13F
Company
0.1%
28,300
$958,000 30 Jun 2021
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.1%
27,100
$917,000 30 Jun 2021
13F
JANE STREET GROUP, LLC
13F
Company
0.09%
25,550
$865,000 30 Jun 2021
13F
Skandinaviska Enskilda Banken AB (publ)
13F
Company
0.09%
25,217
$853,000 30 Jun 2021
13F

Institutional Holders of Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) as of Q3 2021

As of 30 Sep 2021, Arcturus Therapeutics Holdings Inc. - Common Stock (ARCT) was held by 150 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 19,065,552 shares. The largest 10 holders included FEDERATED HERMES, INC., ARK Investment Management LLC, BlackRock Inc., STATE STREET CORP, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., VANGUARD GROUP INC, FMR LLC, Bank Julius Baer & Co. Ltd, Zurich, and ACT Capital, L.L.C.. This page lists 150 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
133
Q3 2021 holders
150
Holder diff
17
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 Value $ Q3 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.